Avanos Medical, Inc.
AVNS
$12.47
$0.040.32%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.64% | -0.53% | 1.36% | 4.27% | -4.57% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.64% | -0.53% | 1.36% | 4.27% | -4.57% |
| Cost of Revenue | 4.21% | 2.24% | 6.28% | 5.01% | -0.51% |
| Gross Profit | 3.16% | -2.72% | -2.25% | 3.72% | -7.68% |
| SG&A Expenses | 13.21% | -5.42% | -18.82% | -9.80% | -4.61% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 30.00% | -160.00% | 2,000.00% | -83.33% | 150.00% |
| Total Operating Expenses | 9.28% | -1.79% | -6.71% | -4.11% | -2.80% |
| Operating Income | -48.24% | 13.01% | 657.14% | 222.95% | -18.27% |
| Income Before Tax | -4,824.72% | 465.38% | 221.57% | 116.48% | -37.76% |
| Income Tax Expenses | -1,019.05% | -41.94% | 337.50% | 176.92% | -145.65% |
| Earnings from Continuing Operations | -3,709.09% | 167.05% | 200.00% | 106.41% | 13.40% |
| Earnings from Discontinued Operations | 40.00% | -131.37% | 96.08% | -119.18% | -106.94% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3,883.81% | 216.22% | 102.64% | -80.00% | -37.87% |
| EBIT | -48.24% | 13.01% | 657.14% | 222.95% | -18.27% |
| EBITDA | -30.18% | 22.61% | 144.68% | 215.00% | -16.67% |
| EPS Basic | -3,899.82% | 218.20% | 102.69% | -82.24% | -37.45% |
| Normalized Basic EPS | -53.54% | 31.90% | 332.01% | 155.41% | -20.02% |
| EPS Diluted | -3,900.70% | 205.80% | 102.47% | -50.38% | -37.45% |
| Normalized Diluted EPS | -53.14% | 30.24% | 329.96% | 154.84% | -19.84% |
| Average Basic Shares Outstanding | -0.43% | -1.71% | -1.92% | -0.86% | -0.65% |
| Average Diluted Shares Outstanding | -1.29% | -0.43% | -1.07% | 0.21% | -0.85% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
